Malignant mesothelioma (MM), especially its more frequent form, malignant pleural
mesothelioma (MPM), is a devastating thoracic cancer with limited therapeutic options …

Small cell lung cancer (SCLC) is the most aggressive carcinoma in thoracic oncology,
unfortunately, despite chemotherapy, relapse is constant. The effect of etoposide, a major …

Optical molecular imaging, a new medical imaging technique, is developed based on
genomics, proteomics and modern optical imaging technique, characterized by non …

This study aimed to prepare efficient cRGDyK peptide-decorated micelles for the targeted
therapy of non-small-cell lung cancer (NSCLC). An amphiphilic copolymer N-succinyl …

Purpose The aim of this work was to establish a novel orthotopic human non-small cell lung
cancer (NSCLC) murine xenograft model by a nonsurgical, transbronchial approach …

Background This study is to investigate whether liposome-loaded nanobubbles (NBs) have
the potentials to carry anti-pro-gastrin releasing peptide (proGRP) antibody and enhance …

With more patients dying from metastasis than from primary cancers, metastasis is a very
important area in cancer research. Investigators thereby heavily rely on animal models of …

Objective: Clinically relevant animal models of non-small cell lung carcinoma (NSCLC) are
required for the validation of novel treatments. We compared two different orthotopic …

Tissue factor pathway inhibitor-2 (TFPI-2) is a potent inhibitor of plasmin, a protease which is
involved in tumour progression by activating (MMPs). This therefore makes TFPI-2 a …

Small cell lung cancer (SCLC) is a highly aggressive subtype of lung cancer with very poor
prognosis due to early metastatic spread and development of chemoresistance. In the last …